Monitoring and evaluation of breast cancer screening programmes: selecting candidate performance indicators

Mostra el registre complet Registre parcial de l'ítem

• dc.contributor.author Muratov, Sergei
• dc.contributor.author Castells, Xavier
• dc.contributor.author Broeders, Mireille
• dc.contributor.author ECIBC Contributor Group
• dc.date.accessioned 2021-05-27T06:54:02Z
• dc.date.available 2021-05-27T06:54:02Z
• dc.date.issued 2020
• dc.description.abstract Background: In the scope of the European Commission Initiative on Breast Cancer (ECIBC) the Monitoring and Evaluation (M&E) subgroup was tasked to identify breast cancer screening programme (BCSP) performance indicators, including their acceptable and desirable levels, which are associated with breast cancer (BC) mortality. This paper documents the methodology used for the indicator selection. Methods: The indicators were identified through a multi-stage process. First, a scoping review was conducted to identify existing performance indicators. Second, building on existing frameworks for making well-informed health care choices, a specific conceptual framework was developed to guide the indicator selection. Third, two group exercises including a rating and ranking survey were conducted for indicator selection using pre-determined criteria, such as: relevance, measurability, accurateness, ethics and understandability. The selected indicators were mapped onto a BC screening pathway developed by the M&E subgroup to illustrate the steps of BC screening common to all EU countries. Results: A total of 96 indicators were identified from an initial list of 1325 indicators. After removing redundant and irrelevant indicators and adding those missing, 39 candidate indicators underwent the rating and ranking exercise. Based on the results, the M&E subgroup selected 13 indicators: screening coverage, participation rate, recall rate, breast cancer detection rate, invasive breast cancer detection rate, cancers > 20 mm, cancers ≤10 mm, lymph node status, interval cancer rate, episode sensitivity, time interval between screening and first treatment, benign open surgical biopsy rate, and mastectomy rate. Conclusion: This systematic approach led to the identification of 13 BCSP candidate performance indicators to be further evaluated for their association with BC mortality.
• dc.format.mimetype application/pdf
• dc.identifier.citation Muratov S, Canelo-Aybar C, Tarride JE, Alonso-Coello P, Dimitrova N, Borisch B, et al. Monitoring and evaluation of breast cancer screening programmes: selecting candidate performance indicators. BMC Cancer. 2020 Aug 24; 20(1): 795. DOI: 10.1186/s12885-020-07289-z
• dc.identifier.doi http://dx.doi.org/10.1186/s12885-020-07289-z
• dc.identifier.issn 1471-2407
• dc.identifier.uri http://hdl.handle.net/10230/47665
• dc.language.iso eng
• dc.publisher BioMed Central
• dc.rights © The Author(s). 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data ma
• dc.rights.accessRights info:eu-repo/semantics/openAccess
• dc.rights.uri http://creativecommons.org/licenses/by/4.0/
• dc.subject.keyword Breast neoplasms/diagnostic imaging
• dc.subject.keyword Early detection of Cancer/methods
• dc.subject.keyword Female
• dc.subject.keyword Health care/standards
• dc.subject.keyword Mass screening/methods
• dc.subject.keyword Programme evaluation
• dc.subject.keyword Quality indicators
• dc.title Monitoring and evaluation of breast cancer screening programmes: selecting candidate performance indicators
• dc.type info:eu-repo/semantics/article
• dc.type.version info:eu-repo/semantics/publishedVersion